March 5 (Reuters) - Sinco Pharmaceuticals Holdings Ltd
 6833.HK :
    * EXPECTED TO RECORD A CONSOLIDATED NET PROFIT OF ABOUT
RMB22
MILLION TO RMB32 MILLION FOR YEAR
    * EXPECTED RESULT DUE TO OVERALL DECREASE IN GROUP'S SELLING
AND
DISTRIBUTION EXPENSES IN CURRENT PERIOD
    * SINCO PHARMACEUTICALS HOLDINGS LTD SEES FY CONSOL NET
PROFIT OF
ABOUT RMB22 MILLION TO RMB32 MILLION VERSUS LOSS OF RMB280.6
MILLION

Source text for Eikon:  urn:newsml:reuters.com:*:nHKS6pWfvp
Further company coverage:  6833.HK 

 (Reuters.Briefs@thomsonreuters.com)